Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
A Navitus Health Solutions survey found 7 in 10 GLP-1 users say cost influenced their treatment decisions, so the move addresses a real barrier, but it also validates the pricing pressure Novo already flagged in its 2026 guidance of -5% to -13% sales growth
If you are taking a related licensed medicine such as semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro), which act on overlapping receptor pathways and are experiencing nausea, it is entirely appropriate to discuss this with your GP or prescriber
Patients who have insurance coverage may pay less
Their healthcare providers take the time to understand your goals, lifestyle, and concerns, helping you choose the treatment option that fits seamlessly into your life
/assets/images/provider/photos/2802570.png)
